Search - tctmd.com

Displaying 121 - 140 of 375

Sort: Relevancy | Date

Presentation TCT 2019

STOPDAPT, SMART-CHOICE, and TWILIGHT: Will These Trials Change Your Clinical Practice?

Presenter: Aditya Kapoor

September 28, 2019

Presentation TCT 2019

PENDULUM Registry: Relationship Between Platelet Reactivity and 1-Year Ischemic and Bleeding Outcomes After PCI

Presenter: Masato Nakamura

September 28, 2019

Presentation TCT 2019

STOPDAPT-2 HBR: 1-Year Outcomes From a Randomized Trial of Clopidogrel Monotherapy vs. DAPT Beginning 1 Month After PCI in Patients at High Bleeding Risk

Presenter: Hirotoshi Watanabe

September 28, 2019

Presentation TCT 2019

AUGUSTUS: Hospitalizations From a 2x2 Factorial Randomized Trial of Apixaban vs. Warfarin and Aspirin vs. Placebo in Patients With Atrial Fibrillation

Presenter: Amit Vora

September 28, 2019

Presentation TCT 2019

TICAKOREA: A Randomized Trial of Ticagrelor vs. Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive Management

Presenter: Duk-Woo Park

September 28, 2019

Presentation TCT 2019

Emergent Drugs and Local Drug Delivery Systems

Presenter: Juan Granada

September 28, 2019

Presentation TCT 2019

DISRUPT CAD II: A Single-Arm Study of Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Stenoses

Presenter: Carlo Di Mario

September 27, 2019

Presentation TCT 2019

TIRATROP: A Double-Blind Randomized Trial of Ticagrelor in Patients Undergoing High-Speed Rotational Atherectomy

Presenter: Thibault Lhermusier

September 27, 2019

Presentation TCT 2019

SECURE-PCI: 1-Year Outcomes From a Randomized Trial of a Loading Dose of Atorvastatin in Patients With ACS and Planned PCI

Presenter: Otavio Berwanger

September 27, 2019

Presentation TCT 2019

GLOBAL LEADERS: Ticagrelor Monotherapy vs. DAPT After PCI in TWILIGHT-Like Patients

Presenter: Yoshinobu Onuma

September 27, 2019

Presentation TCT 2019

Clinical Insights: The Evidence and Technique Behind Orbital Atherectomy

Presenter: Ajay Kirtane

September 27, 2019

Presentation TCT 2019

Clinical Trial Design in HBR Patients: Should Risk Scores Be Incoporated?

Presenter: Davide Capodanno

September 27, 2019

Presentation ESC 2019

THEMIS: Ticagrelor Added to Aspirin in Patients with Stable Coronary Disease and Diabetes

Presenter: Deepak Bhatt

September 01, 2019

Presentation

RAS Inhibition Following TAVR

July 29, 2019

Presentation SCCT 2019

Patients with high risk of CAD but no known CAD should go to CTA first vs. Functional first

Presenter: Marcelo F. Di Carli

July 11, 2019

Presentation EuroPCR 2019

Clinical outcome of a novel sirolimus-coated balloon in patients with coronary artery disease EASTBOURNE registry-interim analysis LBCT session

Presenter: Bernardo Cortese

May 21, 2019

Ticagrelor Monotherapy Beyond One Month Versus Conventional Therapy On Adjudicated Ischemic And Bleeding Endpoints Following Drug Eluting Sent Implantation. Primary Results of the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY)

Presentation ACC 2019

Primary Results of the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY)

Presenter: Marco Valgimigli

March 18, 2019

Presentation ACC 2019

First Randomized Human Experience with a Ticagrelor Reversal Agent

Presenter: Deepak L. Bhatt

March 18, 2019

Presentation JIM 2019

Consider Low Dose RIVAROXABAN + SAPT

Presenter: Roxana Mehran

February 15, 2019

Presentation JIM 2019

Clinical case: Management of long-term antithrombotic therapy

Presenter: Giuseppe Tarantini

February 15, 2019

Advertisement

STOPDAPT, SMART-CHOICE, and TWILIGHT: Will These Trials Change Your Clinical Practice?

PENDULUM Registry: Relationship Between Platelet Reactivity and 1-Year Ischemic and Bleeding Outcomes After PCI

STOPDAPT-2 HBR: 1-Year Outcomes From a Randomized Trial of Clopidogrel Monotherapy vs. DAPT Beginning 1 Month After PCI in Patients at High Bleeding Risk

AUGUSTUS: Hospitalizations From a 2x2 Factorial Randomized Trial of Apixaban vs. Warfarin and Aspirin vs. Placebo in Patients With Atrial Fibrillation

TICAKOREA: A Randomized Trial of Ticagrelor vs. Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive Management

Emergent Drugs and Local Drug Delivery Systems

DISRUPT CAD II: A Single-Arm Study of Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Stenoses

TIRATROP: A Double-Blind Randomized Trial of Ticagrelor in Patients Undergoing High-Speed Rotational Atherectomy

SECURE-PCI: 1-Year Outcomes From a Randomized Trial of a Loading Dose of Atorvastatin in Patients With ACS and Planned PCI

GLOBAL LEADERS: Ticagrelor Monotherapy vs. DAPT After PCI in TWILIGHT-Like Patients

Clinical Insights: The Evidence and Technique Behind Orbital Atherectomy

Clinical Trial Design in HBR Patients: Should Risk Scores Be Incoporated?

THEMIS: Ticagrelor Added to Aspirin in Patients with Stable Coronary Disease and Diabetes

RAS Inhibition Following TAVR

Patients with high risk of CAD but no known CAD should go to CTA first vs. Functional first

Clinical outcome of a novel sirolimus-coated balloon in patients with coronary artery disease EASTBOURNE registry-interim analysis LBCT session

Primary Results of the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY)

First Randomized Human Experience with a Ticagrelor Reversal Agent

Consider Low Dose RIVAROXABAN + SAPT

Clinical case: Management of long-term antithrombotic therapy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content